共 50 条
- [21] Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorderEUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S648 - S648Zuddas, A.Banaschewski, T.Nagy, P.Soutullo, C.Yan, B.Caballero, B.Coghill, D.
- [22] Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration studyBMC PHARMACOLOGY & TOXICOLOGY, 2012, 13Babcock, ThomasDirks, BryanAdeyi, BenScheckner, Brian
- [23] Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration studyBMC Pharmacology and Toxicology, 13Thomas BabcockBryan DirksBen AdeyiBrian Scheckner
- [24] Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Randomized-Withdrawal Study DesignJOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (06): : 647 - 657Coghill, David R.Banaschewski, TobiasLecendreux, MichelJohnson, MatsZuddas, AlessandroAnderson, Colleen S.Civil, RichardDauphin, MatthewHiggins, NicholasLyne, AndrewGasior, MariaSquires, Liza A.
- [25] Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment designBEHAVIORAL AND BRAIN FUNCTIONS, 2010, 6Wigal, TimothyBrams, MatthewGasior, MariaGao, JosephSquires, LizaGiblin, John
- [26] Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment designBehavioral and Brain Functions, 6Timothy WigalMatthew BramsMaria GasiorJoseph GaoLiza SquiresJohn Giblin
- [27] A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum DisorderJOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2012, 51 (07): : 733 - 741Harfterkamp, Myriamvan de Loo-Neus, GigiMinderaa, Ruud B.van der Gaag, Rutger-JanEscobar, RodrigoSchacht, AlexanderPamulapati, SireeshaBuitelaar, Jan K.Hoekstra, Pieter J.
- [28] A Randomized, Double-Blind, Placebo-Controlled Study of Atomoxetine in Japanese Children and Adolescents with Attention-Deficit/Hyperactivity DisorderJOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (04) : 341 - 350Takahashi, MichihiroTakita, YasushiYamazaki, KosukeHayashi, TakashiIchikawa, HironobuKambayashi, YasukoKoeda, TatsuyaOki, JunichiSaito, KazuhikoTakeshita, KenzoAllen, Albert J.
- [29] Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity DisorderJOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (12): : 1423 - 1434Childress, Ann C.Lloyd, EricJacobsen, LeslieGunawardhana, LhanooJohnson, Steven A., Jr.Findling, Robert L.
- [30] Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyCLINICAL THERAPEUTICS, 2007, 29 (03) : 450 - 463Biederman, JosephKrishnan, SumaZhang, YuxinMcGough, James J.Findling, Robert L.